-
Posted by
Two Blokes May 15 -
Filed in
Stock
-
2 views
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus”), a leading provider of cheminformatics, biosimulation, simulation-enabled performance and intelligence solutions, and medical communications to the biopharma industry, today announced the release of DILIsym\u00ae 11, the latest version of its flagship quantitative systems toxicology (QST) platform. “Advancing toxicology research and improving the prediction of drug-induced liver injury (DILI) are.
